Location History:
- Portland, OR (US) (2017 - 2022)
- Vancouver, WA (US) (2022)
Company Filing History:
7 out of 10 
1 out of 1 
1 out of 4 Years Active: 2017-2024
Title: Innovator Spotlight: Sean McClain - Pioneering Inducible Coexpression Systems
Introduction:
Sean McClain, a trailblazing inventor based in Portland, OR, has made significant contributions to the field of bioengineering with his groundbreaking work in developing inducible coexpression systems. With a remarkable portfolio of 7 patents to his name, McClain has redefined the possibilities of controlled gene expression within host cells.
Latest Patents:
McClain's latest patents showcase his innovative approach to bioengineering:
1. Host cells for use in an inducible coexpression system: This patent introduces host cells optimized for a controlled induction of gene expression.
2. Vectors for use in an inducible coexpression system: McClain's vector designs allow for precise regulation of gene product expression within the coexpression system.
Career Highlights:
Having worked at Absci LLC and Abisci, LLC, McClain has honed his expertise in bioengineering and brought his groundbreaking ideas to life. Through his relentless pursuit of innovation, he has solidified his position as a thought leader in the industry.
Collaborations:
McClain has collaborated closely with esteemed colleagues such as Mark Valasek and Philip Barish, pooling their diverse skill sets to push the boundaries of bioengineering. Together, they have spearheaded pioneering projects that have had a lasting impact on the field.
Conclusion:
In conclusion, Sean McClain's inventive spirit and dedication to advancing bioengineering have not only earned him recognition within the industry but have also paved the way for future innovations. His pioneering work in inducible coexpression systems stands as a testament to his ingenuity and unwavering commitment to pushing the boundaries of scientific discovery.